Looks like we signed a deal in Aug but it was not PR'd
“In August, the company entered into one of these early collaborative efforts with a large, international pharmaceutical company to demonstrate the broad capabilities of both our proprietary RNAi drug-discovery engine and our … research team.”
That collaboration is focused on optimizing MDRNA’s so-called DiLA2 drug-delivery platform for use in carrying RNAi molecules to a specific, undisclosed tissue system, and is unrelated to the company’s work on liver and bladder delivery, she said. “At this point, we are unable to disclose the name of the company,
News 
Market Data 
Discover 
AI
